A molecular classification approach, utilizing specific tumor markers such as CK7, CK20, MUC1, MUC2, and CDX2, and genes like KRAS, TP53, APC, and PIK3CA, could prove pivotal in refining the classification methodology [29,30]. This evidence concerns the gene MUC2 and neoplasm.